Envista Holdings Corporation $NVST Shares Sold by Amundi

Key Points

• Amundi cut its Envista stake by 93.1% in the second quarter, selling 171,763 shares and retaining 12,812 shares worth approximately $338,000. Other institutional investors, including Arrowstreet Capital and Wellington Management, significantly increased their positions.
• Envista shares were down 5.0% at $23.72, below their 50-day and 200-day moving averages. The company recently beat quarterly earnings and revenue expectations, reporting $0.41 EPS and $730.5 million in revenue, with revenue up 7.1% year over year.
• Analyst sentiment remains positive, with a consensus rating of “Moderate Buy” and an average price target of $29.71. Price targets from analysts range from $28 to $34.

Amundi lessened its stake in Envista Holdings Corporation (NYSE:NVST - Free Report) by 93.1% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 12,812 shares of the company's stock after selling 171,763 shares during the quarter. Amundi's holdings in Envista were worth $338,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in NVST. Arrowstreet Capital Limited Partnership lifted its position in shares of Envista by 341.5% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company's stock worth $72,515,000 after purchasing an additional 2,210,847 shares during the last quarter. Norges Bank purchased a new stake in Envista during the 4th quarter worth about $45,113,000. Wellington Management Group LLP lifted its holdings in Envista by 2,662.1% during the 2nd quarter. Wellington Management Group LLP now owns 1,686,415 shares of the company's stock worth $44,437,000 after buying an additional 1,625,360 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in shares of Envista during the 2nd quarter worth about $37,316,000. Finally, Pzena Investment Management LLC acquired a new position in shares of Envista during the 2nd quarter worth about $30,494,000.

Envista Stock Down 5.0%

Shares of NYSE:NVST opened at $23.72 on Friday. Envista Holdings Corporation has a fifty-two week low of $18.77 and a fifty-two week high of $30.42. The firm's 50-day simple moving average is $27.01 and its 200-day simple moving average is $26.06. The company has a market cap of $3.81 billion, a price-to-earnings ratio of 40.90, a PEG ratio of 1.19 and a beta of 0.86. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company had revenue of $730.50 million for the quarter, compared to analysts' expectations of $716.11 million. During the same quarter in the previous year, the firm posted $0.26 EPS. The firm's quarterly revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, equities research analysts predict that Envista Holdings Corporation will post 1.53 earnings per share for the current year.

Insider Activity at Envista

In other news, SVP Mischa Reis sold 8,000 shares of the stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the completion of the transaction, the senior vice president owned 27,321 shares in the company, valued at $751,327.50. This trade represents a 22.65% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.99% of the company's stock.

Analyst Ratings Changes

Several brokerages have commented on NVST. Deutsche Bank Aktiengesellschaft set a $32.00 price target on shares of Envista in a research note on Thursday, September 3rd. Piper Sandler reaffirmed a "neutral" rating and issued a $28.00 target price (up from $26.00) on shares of Envista in a research report on Thursday, August 6th. Wall Street Zen lowered shares of Envista from a "strong-buy" rating to a "buy" rating in a research note on Saturday, September 5th. Robert W. Baird set a $34.00 price target on shares of Envista in a research report on Thursday, August 6th. Finally, Weiss Ratings raised Envista from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $29.71.

About Envista

Envista Holdings Corporation is a global dental products and technologies company headquartered in Brea, California. The company develops, manufactures and markets products used by dentists, dental specialists, dental laboratories and other oral-care professionals.

Envista's portfolio includes dental imaging and diagnostic systems, digital dentistry and CAD/CAM solutions, dental implants, orthodontic brackets and wires, clear aligner products, endodontic instruments, restorative materials, infection-prevention products and other dental consumables.

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.